A new study using GlycoCheck, and co-authored by GlycoCheck Chief Science Offer, Dr. Hans Vink, reports new findings of research on patients with sepsis.
Our prediction: the world of healthcare will be looking for big solutions that tackle huge problems with tiny blood vessels as the medical community begins to understand more and more that “micro” is getting even smaller.
The MYSTIC study has fueled the hypothesis that COVID-19 is actually a vascular illness and that systemic leakiness and impairment of the endothelial glycocalyx might play a central role in the development of acute respiratory distress syndrome (ARDS) and multi-organ failure.